Diagnosis of subclinical hypothyroidism (SH) is based on interpretation of biochemical tests in the absence of the evident clinical symptoms. Mildly elevated TSH with normal fT 4 are common in adults and the prevalence of this finding is reported to be 1-10% of general population, being higher in the elderly. In pediatric population its prevalence is lower than 2%. Moreover in about 60% of subjects the natural course of SH is a reversal of the elevated TSH to normal values. Only 3% of them progress to overt hypothyroidism with TSH values above 10 mUI/l. The risk of progression is higher in patients with elevated anti-thyroid antibodies and higher degree of hypoechogenicity at thyroid ultrasound. Increased prevalence of SH is described in obese and overweight subjects, children with Down's syndrome, with diabetes type 1 and in girls with Turner's syndrome. Studies regarding the natural history of SH and its consequences in children are scarce and their conclusions are controversial. Meta-analysis of 39 potentially relevant articles showed that SH in children seems to be a remitting process with a low risk of progression toward overt hypothyroidism regardless of the L-T 4 treatment. There was also no clear evidence of the beneficial effect of L-T 4 treatment on psychological and physical development. Replacement therapy did not seem to be justified in children with SH and TSH values between 5 -10 mUI/l, no goiter and negative anti-thyroid antibodies. Therefore decision regarding the treatment of the young patient with elevated TSH but normal fT 4 value continues to be controversial.
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